Cargando…
Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell‐derived organoids
BACKGROUND: Systemic therapy is the primary treatment for advanced thymic malignancies. However, there is an urgent need to improve clinical outcome. Personalized treatment based on predictive biomarkers is a potential approach to address this requirement. In this study, we aimed to show the correla...
Autores principales: | Wu, Yuan‐Hung, Chao, Heng‐sheng, Chiang, Chi‐Lu, Luo, Yung‐Hung, Chiu, Chao‐Hua, Yen, Sang‐Hue, Liu, Chun‐Yu, Chiou, Jeng‐Fong, Burnouf, Thierry, Chen, Yin‐Ju, Wang, Peng‐Yuan, Chao, Tsu‐Yi, Hsu, Shih‐Ming, Lu, Long‐Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481139/ https://www.ncbi.nlm.nih.gov/pubmed/37474689 http://dx.doi.org/10.1111/1759-7714.15039 |
Ejemplares similares
-
Real-world evidence of the intrinsic limitations of PCR-based EGFR mutation assay in non-small cell lung cancer
por: Shen, Chia-I, et al.
Publicado: (2022) -
Comparison of the outcome between immunotherapy alone or in combination with chemotherapy in EGFR-mutant non-small cell lung cancer
por: Shen, Chia-I, et al.
Publicado: (2021) -
Patient-derived organoids as personalized avatars and a potential immunotherapy model in cervical cancer
por: Huang, Hua, et al.
Publicado: (2023) -
Old age and
EGFR
mutation status in inoperable early‐stage non‐small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 patients in Taiwan
por: Wu, Yuan‐Hung, et al.
Publicado: (2023) -
Chemoradiotherapy for Inoperable Carotid Body Leiomyosarcoma: A Case Report and Review of Literature
por: Liu, Cheng-Sheng, et al.
Publicado: (2021)